Low-dose Maximal-intent Versus Controlled-tempo Resistance Training on Quality-of-life in Older Adults

Sponsor
Northumbria University (Other)
Overall Status
Recruiting
CT.gov ID
NCT06124911
Collaborator
(none)
40
1
4
16.1
2.5

Study Details

Study Description

Brief Summary

The aims of this study were to:
  1. Compare the effects of low-dose Maximal Intent and Controlled Tempo Resistance Training on untrained healthy older adults' quality-of-life, functional capacity, and strength.

  2. Qualitatively explore perceptions of Maximal Intent and Controlled Tempo Resistance Training in older adults.

Older adults are defined as being 60 or more years of age.

Condition or Disease Intervention/Treatment Phase
  • Other: Leg Press Resistance Training (3x5)
  • Other: Leg Press Resistance Training (5x5)
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
40 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Comparison of Two Low-dose Resistance Training Modalities on Strength, Functional Capacity, and Quality-of-life in Healthy, Community-dwelling, Untrained Older Adults: a Randomised Controlled Trial
Actual Study Start Date :
May 30, 2023
Anticipated Primary Completion Date :
Sep 30, 2024
Anticipated Study Completion Date :
Sep 30, 2024

Arms and Interventions

Arm Intervention/Treatment
Experimental: Maximal-intent Resistance Training - 3x5 (MI3x5)

The max-intent group were instructed and encouraged to deliberately commit to exerting maximal effort and force during the concentric phase of the leg press with the intention of achieving the greatest velocity possible. This group completed 3 sets of 5 repetitions at 60% one-repetition maximum.

Other: Leg Press Resistance Training (3x5)
Leg Press resistance training at 60% one-rep-max for three sets of five repetitions

Experimental: Maximal-intent Resistance Training - 5x5 (MI5x5)

The max-intent group were instructed and encouraged to deliberately commit to exerting maximal effort and force during the concentric phase of the leg press with the intention of achieving the greatest velocity possible. This group completed 5 sets of 5 repetitions at 60% one-repetition maximum.

Other: Leg Press Resistance Training (5x5)
Leg Press resistance training at 60% one-rep-max for five sets of five repetitions

Experimental: Controlled-tempo Resistance Training - 3x5 (CT3x5)

The controlled-tempo group followed a metronome for both eccentric and concentric phases of the leg press with the intention of maintaining a steady three-second concentric and three-second eccentric. This group completed 3 sets of 5 repetitions at 60% one-repetition maximum.

Other: Leg Press Resistance Training (3x5)
Leg Press resistance training at 60% one-rep-max for three sets of five repetitions

Experimental: Controlled-tempo Resistance Training - 5x5 (CT5x5)

The controlled-tempo group followed a metronome for both eccentric and concentric phases of the leg press with the intention of maintaining a steady three-second concentric and three-second eccentric. This group completed 5 sets of 5 repetitions at 60% one-repetition maximum.

Other: Leg Press Resistance Training (5x5)
Leg Press resistance training at 60% one-rep-max for five sets of five repetitions

Outcome Measures

Primary Outcome Measures

  1. Quality-of-life [At baseline and Week 1, mid (Week 4), and post (Week 9), out of a total study duration of 9 weeks.]

    Participant quality of life (measured through focus group questions & SF-36)

Secondary Outcome Measures

  1. Balance [At baseline and Week 1, mid (Week 4), and post (Week 9), out of a total study duration of 9 weeks.]

    Using the biodex to do a 3 x 20s double-foot eyes-open balance test on Level 6.

  2. 6-minute Walk Test [At baseline and Week 1, mid (Week 4), and post (Week 9), out of a total study duration of 9 weeks.]

    A "brisk"-paced 6-minute walk test.

  3. Timed-up-and-go [At baseline and Week 1, mid (Week 4), and post (Week 9), out of a total study duration of 9 weeks.]

    Standing from a chair, walking to a point 3 metres away, turn, and return to the chair as quick as possible whilst walking.

  4. 30-second sit-to-stand (30s-Sit-to-Stand) [At baseline and Week 1, mid (Week 4), and post (Week 9), out of a total study duration of 9 weeks.]

    Maximal amount of repetitions a participant can stand up from a chair in 30-seconds.

  5. Strength [At baseline and Week 1, mid (Week 4), and post (Week 9), out of a total study duration of 9 weeks.]

    Participants one-repetition max on leg press machine.

  6. Body Mass Index [At baseline and Week 1, mid (Week 4), and post (Week 9), out of a total study duration of 9 weeks.]

    Mass and height will be combined to report BMI in kg/m^2

  7. Strength-to-mass Ratio [At baseline and Week 1, mid (Week 4), and post (Week 9), out of a total study duration of 9 weeks.]

    Mass and Leg Press 1RM will be combined to calculate strength-to-mass ratio.

  8. Leg press one-rep-max velocity pre-to-post [At baseline and Week 1, mid (Week 4), and post (Week 9), out of a total study duration of 9 weeks.]

    Velocity (m/s) of leg press measured at post-intervention, using baseline one-rep-max.

Eligibility Criteria

Criteria

Ages Eligible for Study:
60 Years to 85 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Participants were eligible if they were between 30-60 years old

  • Uninjured

  • Had no cardiovascular or neuromuscular conditions

  • Had not participated in lower-limb resistance training in the previous six months.

Exclusion Criteria:
  • Participants were excluded if they had either taken part in any lower-limb resistance training in the last six months

  • Had underlying health condition(s) that prevented them from participating in resistance training

  • Regularly met or exceeded the UK recommended physical activity guideline of 150-minutes of moderate to intense physical activity per week.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Northumbria University Newcastle Tyne And Wear United Kingdom NE1 8ST

Sponsors and Collaborators

  • Northumbria University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Northumbria University
ClinicalTrials.gov Identifier:
NCT06124911
Other Study ID Numbers:
  • NU2863
First Posted:
Nov 9, 2023
Last Update Posted:
Nov 9, 2023
Last Verified:
Nov 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Northumbria University

Study Results

No Results Posted as of Nov 9, 2023